79 related articles for article (PubMed ID: 2784335)
1. Optimal conditions for in vitro T cell depletion of human bone marrow by Campath-1a plus complement as demonstrated by limiting dilution analysis.
Frame JN; Sheehy D; Cartagena T; Cirrincione C; O'Reilly RJ; Dupont B; Kernan NA
Bone Marrow Transplant; 1989 Jan; 4(1):55-61. PubMed ID: 2784335
[TBL] [Abstract][Full Text] [Related]
2. T-cell depletion of Cercopithecus aethiops monkey bone marrow with Campath-1 monoclonal antibody and complement.
Phan DT; Barta E; Gidáli J; Fehér I; Harsányi V; Petrányi GG; Hollán SR
Haematologia (Budap); 1987; 20(3):155-63. PubMed ID: 3500899
[TBL] [Abstract][Full Text] [Related]
3. T cell depletion of human bone marrow. Comparison of Campath-1 plus complement, anti-T cell ricin A chain immunotoxin, and soybean agglutinin alone or in combination with sheep erythrocytes or immunomagnetic beads.
Frame JN; Collins NH; Cartagena T; Waldmann H; O'Reilly RJ; Dupont B; Kernan NA
Transplantation; 1989 Jun; 47(6):984-8. PubMed ID: 2660360
[TBL] [Abstract][Full Text] [Related]
4. Thy-1 antigen expression by murine high-proliferative capacity hematopoietic progenitor cells. I. Relation between sensitivity to depletion by Thy-1 antibody and stem cell generation potential.
Boswell HS; Wade PM; Quesenberry PJ
J Immunol; 1984 Dec; 133(6):2940-9. PubMed ID: 6149245
[TBL] [Abstract][Full Text] [Related]
5. Purification of peripheral blood hematopoietic cells using Campath-1M monoclonal antibody.
Law P; Chau WK; Dooley DC
Exp Hematol; 1990 May; 18(4):289-93. PubMed ID: 2323363
[TBL] [Abstract][Full Text] [Related]
6. Thy-1 is a differentiation antigen that characterizes immature murine erythroid and myeloid hematopoietic progenitors.
Miller BA; Lipton JM; Linch DC; Burakoff SJ; Nathan DG
J Cell Physiol; 1985 Apr; 123(1):25-32. PubMed ID: 2857726
[TBL] [Abstract][Full Text] [Related]
7. Cercopithecus aethiops monkey as a reliable model for in vitro study of T cell depletion of bone marrow with Campath-1 plus complement.
Phan DT; Benczur M; Gidáli J; Fehér I; Harsányi V; Nemes L; Petrányi G; Hollán SR
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):97-106. PubMed ID: 2472335
[TBL] [Abstract][Full Text] [Related]
8. Comparison of three techniques for the ex vivo elimination of T cells from human bone marrow.
Blazar BR; Quinones RR; Heinitz KJ; Sevenich EA; Filipovich AH
Exp Hematol; 1985 Feb; 13(2):123-8. PubMed ID: 3882442
[TBL] [Abstract][Full Text] [Related]
9. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
10. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
Siena S; Villa S; Bonadonna G; Bregni M; Gianni AM
Transplantation; 1987 Mar; 43(3):421-6. PubMed ID: 3103275
[TBL] [Abstract][Full Text] [Related]
11. Selective depletion of human myeloma clonogenic stem cells from bone marrow cell preparations by a plasma-cell reactive antibody and complement.
Stone MJ; Tong AW; Fay JW; Lee JC
Cancer Detect Prev; 1988; 12(1-6):621-35. PubMed ID: 3180147
[TBL] [Abstract][Full Text] [Related]
12. Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies.
Vartdal F; Kvalheim G; Lea TE; Bosnes V; Gaudernack G; Ugelstad J; Albrechtsen D
Transplantation; 1987 Mar; 43(3):366-71. PubMed ID: 3103274
[TBL] [Abstract][Full Text] [Related]
13. Quantity and nature of residual bone marrow T cells after treatment of the marrow with Campath-1.
Irlé C; Kaestli M; Aapro M; Chapuis B; Jeannet M
Exp Hematol; 1987 Feb; 15(2):163-70. PubMed ID: 3545877
[TBL] [Abstract][Full Text] [Related]
14. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficiency of complements from various species for T-cell depletion from Cercopithecus aethiops bone marrow with Campath-1 MoAb in vitro.
Phan DT; Gidáli J; Fehér I; Harsányi V; Petrányi GG; Hollán SR
Haematologia (Budap); 1987; 20(4):203-13. PubMed ID: 3501389
[TBL] [Abstract][Full Text] [Related]
16. The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells.
Morecki S; Nabet C; Ackerstein A; Schlesinger M; Slavin S
Bone Marrow Transplant; 1991 Apr; 7(4):269-73. PubMed ID: 2070132
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
[TBL] [Abstract][Full Text] [Related]
18. [Quantitative determination of human bone marrow T cells following in vitro depletion by Campath-1 monoclonal antibody].
Irlé C; Kaestli M; Chapuis B; Jeannet M
Schweiz Med Wochenschr; 1985 Oct; 115(43):1517-8. PubMed ID: 3909385
[TBL] [Abstract][Full Text] [Related]
19. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
Lu L; Pelus LM; Broxmeyer HE
Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046
[TBL] [Abstract][Full Text] [Related]
20. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]